Buy NOOT (Lemon Tek) Microdose Mushroom Capsules
NOOT (Lemon Tek) Microdose Mushroom Capsules offer the highest dose of active medicinal mushrooms on the market. This crafted formulation promises to enhance your existential experience and encourage a greater spiritual connection. Get closer to consciousness faster. NOOT (Lemon Tek) Microdose Mushroom Capsules
All-natural crystallized lemon is blended with a healthy dose of psilocybe cubensis to promote fast activation and provide a calm and soothing recovery. Best suited for experienced users because of its quick come-up and potent effects. Great for people looking to generate positive feelings, higher appreciation, and sacred experiences.
The formula is targeting your best experience. Our all-natural crystallized lemon will activate your experience and elevate! These all-natural blends will deliver the vitamins needed to keep you energized through the day/night. The recovery will be easier and get you ready for the next trip!
Recommend Use: Elevates consciousness and provides a playful, energetic journey. Suitable for experienced users.
Recommended Dosage: Adults take 1 capsule. Take with water.
Package: Each box contains 10 capsules. Each capsule is 500mg for a total of 5,000mg.
- Psilocybe cubensis — 400 mg
- Crystalized lemon — 150 mg
The benefits of full-dose psychedelics
While more than a thousand early studies linked psychedelic use with beneficial effects , there was a 40-year pause on psychedelic research following the prohibition of these substances . Despite continued prohibition, modern research has revealed the promising potential of LSD and psilocybin for treating alcohol and tobacco dependence [, depression , and end-of-life anxiety [, while related research on 3,4-methylenedioxymethamphetamine (MDMA) has shown great promise for treating post-traumatic stress disorder [. Psychedelics can also increase openness and occasion mystical-type experiences in healthy controls ]. As full-dose psychedelics appear to aid in the relief of severe, chronic psychiatric conditions (e.g. depression, anxiety, PTSD), milder mental health concerns may plausibly be treated by lower, recurring doses. This is especially worth considering if certain full-dose outcomes are found to rely on purely pharmacologic mechanisms rather than primarily on phenomenological experiences.